A new survey finds most Canadian girls and their parents want young women to be vaccinated against the virus that causes genital warts and cervical cancer.
In this survey of girls aged 13 to 17 and their parents in Nova Scotia, more than 75 per cent said they would accept use of the recently approved vaccine against four strains of the sexually transmitted human papillomavirus, or HPV.
Monique MacFarlane Conrad led the study by the Canadian Centre for Vaccinology in Halifax.
The vaccine, sold by Merck Frosst Canada under the brand name Gardasil, was approved for use by Health Canada in July for females aged nine to 26. The vaccine is administered in three doses over a six-month period.